The MARKET has already told YOU!

Founders raising equity often describe themselves as still "waiting" to see how the market responds, months after the market responded several times. The responses are usually indicative offers, term sheets, and in some cases full subscription documents. Each carried ownership requirements, control provisions, conditions precedent attached to the release of funds, or seniority in the recovery order that the founder found unacceptable. Each was declined, and in the founder's account of the raise those documents stopped existing at the moment of decline.

This produces a strange piece of internal accounting. 

The headline capital gets recorded as the offer while the economics and control sections that govern how the capital behaves get recorded as a personality problem belonging to the investor. 

• "They wanted too much." 

• "They didn't understand the sector." 

• "They were unusually cautious for people in the business of taking risk." 

Each observation may be accurate about the individual BUT none of them alters what the document contained.

An offer is a single instrument, and the amount is one clause inside it. The subscription price and whether the option pool sits inside the pre-money or the post-money figure, the liquidation preference and whether it participates beyond its multiple, the anti-dilution formula and whether adjustment runs on a weighted average or a full ratchet, board composition and observer rights, the schedule of reserved matters requiring investor consent, any registered security interest over intellectual property or the underlying asset, the conditions precedent governing each tranche, reverse vesting on founder shares, redemption rights, drag-along thresholds, information covenants: these describe the conditions under which that investor is willing to hold this specific risk. Remove the conditions and nothing cleaner remains underneath. 

What remains is a number nobody agreed to provide on the founder's preferred basis.

Terms from one investor tell you about that investor. Their mandate, their fund vintage and remaining life, their cost of capital, their reserve ratio for follow-on rounds, their concentration limits, the loss taken three years ago that permanently changed how they treat security over core assets. Terms from several unrelated investors form a different category of information. Those parties are not coordinating. They operate different sources of money, different sector fluency, different appetites, different reasons to decline. 

When people working from unrelated positions land on similar protections, the similarity describes the case rather than the people.

The demands are usually specific enough to be read directly by anyone willing to look at the mechanics rather than the tone: 

1. An investor requiring a larger share than the founder expected is applying a heavier discount to the forecast and adjusting through ownership rather than arguing about the valuation line, which is the faster negotiation and the one that survives contact with an investment committee. 

2. An investor requiring a registered security interest over the core asset, with step-in rights and reversion of any license on default, is underwriting to collateral rather than to forecast performance, and will usually add a negative pledge preventing further encumbrance of the same asset. 

3. An investor releasing funds in tranches against defined conditions precedent is buying an option to abandon, limiting capital at risk to the current stage and pricing the balance of the plan at zero until it is evidenced. 

4. An investor negotiating hardest over the preference stack, subordination of founder loans, and any escrow or holdback is planning the recovery order for outcomes in which the equity is worthless, which is where most of their portfolio arithmetic actually lives. 

Read together, repeated demands map where professionals believe the durable value sits and who they expect to absorb the damage.

Founders generally answer by returning to the asset base. There is a slate, a library, a granted patent family with national phase entries completed, a site with permissions in place, a brand with measurable recognition, signed partnerships with credible counterparties, relationships with buyers that took a decade to build, a route to market competitors cannot easily copy. All of it can be real and all of it can strengthen an investment case. Investors assess it through a narrower question than founders enjoy answering. 

They want to know what the asset has produced commercially and what has been secured contractually, then whether the contract in question is enforceable, assignable on a change of control, free of termination for convenience, and unencumbered by prior grants. An option to acquire is not a licence. A letter of intent typically binds nobody beyond its confidentiality and exclusivity provisions. A partnership agreement loaded with conditions precedent generates no revenue share until those conditions are satisfied. An estimate from a sales agent carries none of the weight of a minimum guarantee backed by a creditworthy party, which is why the two are never treated as the same line. 

Anything that has not converted is valued as potential, and potential is the specific thing investors purchase through ownership rather than through a premium on the founder's number.

The founder's rebuttal at this stage is legitimate. Proof of the kind investors want requires the funding: 

• Distribution performance requires a finished product. 

• Clinical data requires a paid trial. 

• Stabilised income requires a completed building and a leasing period. 

Pre-revenue companies live inside that difficulty and cannot argue their way out of it. Investors do not dispute the difficulty. They price it, because they cannot verify the forecast independently and will not fund on the strength of representations alone. Ownership share, reserved matters, milestone tranches, and seniority in the recovery order exist to carry the distance between the plan and the evidence. The founder asks who bears the uncertainty. The terms answer, repeatedly, in language the founder keeps classifying as rudeness.

Searching outside the traditional funding channels rarely improves the answer. The assumption is that capital unfamiliar with the sector will be less demanding, having fewer scars. Unfamiliarity is itself a risk that gets priced. An investor without sector experience holds no comparables against which to test the budget, no view on which lines are habitually understated, no capacity to operate or complete the asset if the founder departs, and no network capable of extracting value in a distressed sale. Control substitutes for the knowledge they do not have. 

Founders who widen the search on this reasoning frequently return holding proposals with personal or completion guarantees, controlled accounts with independent signatories, tighter reporting covenants, and a longer schedule of reserved matters than the specialists proposed, which they then interpret as further evidence that nobody understands the business.

Rejection can still be the correct commercial decision. Certain conditions genuinely destroy what is being built. Assigning copyright or granting first-ranking security over the only asset can leave a residual worth nothing once the preference stack is satisfied, which converts the founder's remaining equity into a paper position. A control package transferring the reserved matters that only the founder knows how to decide can defeat the purpose of taking the funding at all. 

Declining a structure that damages the company is ordinary judgement rather than weakness or vanity. Declining changes only whether a transaction occurs. The assessment behind the terms survives intact, held by a firm that has formed a view and will remember it when the name appears again.

Qualified investors for any specific profile form a finite population, and in most sectors a small and interconnected one. Every approach made with an unrevised case consumes one of them, usually permanently, since a second review of unchanged materials eight months later is rare while the memory of the first meeting is not. The founder pays twice. Once in the relationship, which does not regenerate. Once in the months spent repeating the same conversation with progressively less suitable counterparties while the weakness identified in the first meeting sits exactly where it was found. Correction is frequently cheaper than continued search. One contracted commitment, one signed distribution or off-take agreement, one paying customer, one milestone completed at the company's own expense moves an item from forecast into contracted, and contracted is the column that changes what investors are prepared to accept and what they need to secure in order to accept it.

When unrelated qualified investors repeatedly request similar protections, treat the repetition as evidence about the current investment case and resolve what it identifies before approaching additional people. This is not an instruction to sign unfavorable terms. It is recognition that a group of professionals with money at stake and no incentive to flatter anyone has told you how the risk reads from outside the company, at no cost, several times over.

Founders who work through the repetition tend to find the next round of conversations shorter and the terms materially different, because the case changed rather than the audience. Founders who classify every declined offer as a failure of fit continue describing the market as unresponsive while steadily exhausting it.

How many named specific investors have already given you the same answer, and what is your justification for recording that as silence?

What is your Risk Adjusted Project Profile?